$3.3B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC Apogee Therapeutics Inc | 8.5M | +0.0% | $1.1B | 34.2% |
| 2 | ORKA Oruka Therapeutics Inc | 4.1M | +0.0% | $395M | 12.0% |
| 3 | ERAS Erasca Inc | 17.9M | +9.2% | $328M | 9.9% |
| 4 | SYRE Spyre Therapeutics Inc | 3.0M | −19.0% | $265M | 8.0% |
| 5 | DNTH Dianthus Therapeutics Inc | 1.2M | +0.0% | $115M | 3.5% |
| 6 | OCUL Ocular Therapeutix Inc | 10.3M | +0.0% | $102M | 3.1% |
| 7 | DMRA Damora Therapeutics Inc | 3.6M | +0.0% | $94M | 2.8% |
| 8 | SVRA Savara Inc | 14.7M | +7.3% | $91M | 2.8% |
| 9 | JBIO Jade Biosciences Inc | 3.2M | +0.0% | $72M | 2.2% |
| 10 | COGT Cogent Biosciences Inc | 1.6M | −17.9% | $64M | 1.9% |
| 11 | VRDN Viridian Therapeutics Inc | 3.3M | −16.1% | $60M | 1.8% |
| 12 | VOR Vor Biopharma Inc | 3.0M | +0.0% | $56M | 1.7% |
| 13 | DYN Dyne Therapeutics Inc | 2.2M | +0.0% | $48M | 1.5% |
| 14 | MAZE Maze Therapeutics Inc | 1.6M | +0.0% | $48M | 1.4% |
| 15 | RLMD Relmada Therapeutics Inc | 6.8M | +41.3% | $47M | 1.4% |
| 16 | ORIC Oric Pharmaceuticals Inc | 4.3M | +0.0% | $47M | 1.4% |
| 17 | CBIO Crescent Biopharma Inc. | 2.1M | +0.0% | $38M | 1.2% |
| 18 | ZURA Zura Bio Ltd | 6.4M | +0.0% | $38M | 1.2% |
| 19 | ANL Adlai Nortye Ltd | 3.2M | +0.0% | $37M | 1.1% |
| 20 | ELVN Enliven Therapeutics Inc | 526,331 | −69.5% | $27M | 0.8% |
| 21 | CYBIN INC Cybin Inc | 3.9M | +0.0% | $25M | 0.8% |
| 22 | CGEM Cullinan Therapeutics Inc | 1.4M | +0.0% | $25M | 0.8% |
| 23 | IPSC Century Therapeutics Inc | 8.7M | +0.0% | $21M | 0.6% |
| 24 | ARTV Artiva Biotherapeutics Inc | 2.0M | +27.0% | $20M | 0.6% |
| 25 | CTMX Cytomx Therapeutics Inc. | 5.0M | −50.1% | $19M | 0.6% |
| 26 | QUIT Achieve Life Science Inc | 2.8M | — | $18M | 0.5% |
| 27 | PBLS Parabilis Medicines Inc | 625,000 | — | $17M | 0.5% |
| 28 | SRZN Surrozen Inc | 632,931 | +0.0% | $16M | 0.5% |
| 29 | KRRO Korro Bio Inc | 1.0M | +0.0% | $13M | 0.4% |
| 30 | ANRO Alto Neuroscience Inc | 500,000 | +0.0% | $13M | 0.4% |
| 31 | XFOR X4 Pharmaceuticals Inc | 1.9M | +485.2% | $9M | 0.3% |
| 32 | RACC Research Alliance Corp Iii | 300,000 | — | $3M | 0.1% |
| 33 | MTRI Inmed Pharmaceuticals Inc | 32,685 | — | $50,662 | 0.0% |